Superior efficacy of liposomal amphotericin B with prolonged circulation in blood in the treatment of severe candidiasis in leukopenic mice
January 1998
Article
| Related Files |
|---|
|
(9736577.pdf, 0.1MB) |
In leukopenic mice with severe systemic candidiasis, single-dose treatment (5 mg of amphotericin B [AMB]/kg of body weight) with long-circulating polyethylene glycol-coated AMB liposomes (PEG-AMB-LIP) resulted in zero mortality and a significant reduction in the number of viable Candida albicans in the kidney, whereas 70% mortality was seen in mice treated with five daily doses of AmBisome (5 mg of AMB/kg . day). When the first of five daily doses of AmBisome was combined with a single low dose of Fungizone (0.1 mg of AMB/kg), the efficacy was equal to that of PEG-AMB-LIP.
Keywords
- Animals
- Mice
- Liposomes
- Drug Carriers
- Leukopenia/*complications
- Candidiasis/*drug therapy
- Antibiotics, Antifungal/*administration & dosage
- Amphotericin B/*administration & dosage/blood
Automatically Extracted Terms
- treatment
- ambisome
- albicans
- peg-amb-lip
- fungizone
- inoculation
- albicans inoculation
- number
- efficacy
- antifungal activity
- amb /kg
- multidose ambisome
- kidney
- multidose
- effect
- antifungal
- amb /kg day
- table
- liposomes
- leukopenic